CCRC - Certified Clinical Research Coordinator Informed Consent Process Questions and Answers — Questions and Answers
Question 1: A potential participant in a clinical trial is fully fluent in Spanish but has limited English proficiency. The IRB-approved informed consent form (ICF) is only available in English. Which of the following is the most appropriate action for the Clinical Research Coordinator (CRC) to take?
- Use a qualified, impartial interpreter to translate the English ICF to the participant during the consent discussion and document the process thoroughly.
- Proceed with the consent process using the English ICF and have a bilingual site staff member informally translate key sections.
- Provide the participant with the English ICF and ask them to use a consumer translation app on their phone for understanding.
- Inform the participant they cannot be enrolled until an official, IRB-approved Spanish translation of the ICF is available. (Correct answer)
Correct answer: Inform the participant they cannot be enrolled until an official, IRB-approved Spanish translation of the ICF is available.
According to ICH GCP and FDA regulations, the informed consent information must be provided in a language understandable to the subject. Using an unapproved, on-the-spot translation does not meet regulatory standards. The correct and ethical procedure is to use an IRB-approved translated consent form to ensure the participant fully understands the study, its risks, and their rights before providing consent.
Question 2: Which of the following is a primary responsibility of the CRC during the informed consent process?
- Determining the participant's medical eligibility for the study.
- Ensuring the investigator has signed the ICF before the participant.
- Assessing the potential participant's understanding of the study information provided. (Correct answer)
- Deciding on the compensation amount for study participation.
Correct answer: Assessing the potential participant's understanding of the study information provided.
While the CRC has many roles, a key ethical and regulatory responsibility is to ensure the participant truly understands the study. This involves more than just presenting information; it includes asking open-ended questions, using teach-back methods, and assessing both verbal and non-verbal cues to confirm comprehension before the participant signs the form.
Question 3: A participant has been enrolled in a long-term oncology trial for two years. The sponsor issues a protocol amendment that introduces a new, optional sub-study involving additional blood draws to test for a novel biomarker. What is the CRC's responsibility regarding the informed consent for this change?
- Obtain verbal consent from the participant for the sub-study and document it in the progress notes.
- No action is needed as the main study consent covers minor additions.
- Inform the participant of the new sub-study during their next visit without requiring a signature.
- Ensure the participant is re-consented using a new, IRB-approved consent form that details the optional sub-study. (Correct answer)
Correct answer: Ensure the participant is re-consented using a new, IRB-approved consent form that details the optional sub-study.
Significant new information, such as additional procedures or changes in risk, requires that participants be re-consented. The CRC must use a revised, IRB-approved informed consent form to explain the changes and document the participant's willingness to continue in the trial under the new conditions.
Question 4: According to federal regulations (45 CFR 46 and 21 CFR 50), the informed consent process must minimize the possibility of coercion or undue influence. Which scenario best exemplifies undue influence?
- A CRC offers a potential participant an IRB-approved compensation of $50 for each study visit to cover time and travel.
- An investigator tells their own patient that their access to standard medical care will be limited if they do not enroll in the clinical trial.
- A CRC provides a potential participant with a thorough explanation of the study in a private, quiet room.
- An investigator offers an excessively large monetary payment to a financially vulnerable individual to encourage enrollment in a high-risk study. (Correct answer)
Correct answer: An investigator offers an excessively large monetary payment to a financially vulnerable individual to encourage enrollment in a high-risk study.
Undue influence occurs when an excessive or inappropriate reward is offered to obtain compliance, which can compromise a person's judgment. While compensating participants is acceptable, an amount that is disproportionate to the study's demands, especially when offered to a vulnerable population, is considered undue influence. Telling a patient their care depends on participation is an example of coercion (a threat of harm).
Question 5: During an informed consent discussion for a pediatric study, the CRC must obtain permission from the parents/legal guardian. What additional step is typically required for the pediatric participant?
- Having the child sign the full informed consent form.
- Obtaining the child's assent using an age-appropriate form and discussion. (Correct answer)
- Documenting the child's verbal agreement in the source documents.
- No additional step is needed if the parents provide consent.
Correct answer: Obtaining the child's assent using an age-appropriate form and discussion.
For research involving minors who have some capacity to understand, regulations and ethical guidelines require obtaining the child's affirmative agreement, known as assent, in addition to the permission of the parents or legally authorized representative. The assent process and form should be tailored to the child's age and developmental level.
Question 6: An investigator delegates the task of obtaining informed consent to the CRC. The consent form is signed and dated by the participant and the CRC. Later, a monitor reviewing the study files notes an error. Which of the following represents a common and significant documentation error in the informed consent process?
- The participant was given a copy of the signed consent form to take home.
- The consent discussion took place in a private examination room.
- The version of the consent form used was outdated and had been superseded by a more recent IRB-approved version. (Correct answer)
- The CRC who obtained consent was listed on the delegation of authority log for that task.
Correct answer: The version of the consent form used was outdated and had been superseded by a more recent IRB-approved version.
Using an outdated or incorrect version of the informed consent form is a serious regulatory violation and a common finding in audits and inspections. The CRC is responsible for ensuring that only the most current, IRB-approved version of the ICF is used for every participant enrollment.
CCRC - Certified Clinical Research Coordinator Informed Consent Process Questions and Answers
A potential participant in a clinical trial is fully fluent in Spanish but has limited English proficiency.
The IRB-approved informed consent form (ICF) is only available in English.
Which of the following is the most appropriate action for the Clinical Research Coordinator (CRC) to take?